Literature DB >> 29663834

Murine models of psoriasis and their usefulness for drug discovery.

Shih-Yi Chuang1, Chih-Hung Lin2, Calvin T Sung3, Jia-You Fang1,4,5,6.   

Abstract

INTRODUCTION: Psoriasis is an autoimmune skin disease characterized by red plaques with silver or white multilayered scales with a thickened acanthotic epidermis. Using mouse models of cutaneous inflammation, IL-23/Th17 was identified to have a potential key role in psoriasis. New treatments to slow this inflammatory skin disorder are urgently needed. To aid their discovery, a psoriasis animal model mimicking human psoriasis is urgently needed for their early preclinical evaluation. Areas covered: The authors review animal models of psoriasis and analyze the features and molecular mechanisms involved in these mouse models. The application of various mouse models of psoriasis for drug discovery and development has also been reviewed and the possible molecular targets in psoriasis for future anti-psoriatic drug design is discussed. Expert opinion: So far, it has been difficult to create an animal model that exactly simulates a human disease or condition. The xenotransplantation model is regarded as the closest to incorporating the complete genetic, phenotypic, and immunopathogenic processes of psoriasis. However, the imiquimod (IMQ)-induced model is the most prevalent among psoriatic mouse models due to its ease of use, convenience, and low cost. Further efforts to develop psoriasis-like skin models in mice are needed for the study and treatment of this complex disease.

Entities:  

Keywords:  IL-23/Th17; Psoriasis; animal model; drug development; murine

Mesh:

Substances:

Year:  2018        PMID: 29663834     DOI: 10.1080/17460441.2018.1463214

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  15 in total

Review 1.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 2.  The bioactivities of resveratrol and its naturally occurring derivatives on skin.

Authors:  Ming-Hsien Lin; Chi-Feng Hung; Hsin-Ching Sung; Shih-Chun Yang; Huang-Ping Yu; Jia-You Fang
Journal:  J Food Drug Anal       Date:  2021-03-15       Impact factor: 6.157

3.  Intervention Mechanism of Hunag-Lian Jie-Du Decoction on Canonical Wnt/β-Catenin Signaling Pathway in Psoriasis Mouse Model.

Authors:  Xuesong Yang; Guangyun Luo; Lan Fu; Hong Huang; Lifen Wang; Lihua Yin; Xuelian Zhang; Tingting Wang; Xuan Ma; Tianyu Feng; Jianzhou Ye
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-14       Impact factor: 2.650

Review 4.  Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis.

Authors:  Tse-Hung Huang; Chwan-Fwu Lin; Ahmed Alalaiwe; Shih-Chun Yang; Jia-You Fang
Journal:  Int J Mol Sci       Date:  2019-05-24       Impact factor: 6.208

5.  Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment.

Authors:  Immo Prinz; Inga Sandrock; Ulrich Mrowietz
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

6.  Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages.

Authors:  Bhakta Prasad Gaire; Chi-Ho Lee; Wondong Kim; Arjun Sapkota; Do Yup Lee; Ji Woong Choi
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

7.  Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist.

Authors:  Qingran Li; Weiping Liu; Shidong Gao; Yao Mao; Yanfei Xin
Journal:  BMC Immunol       Date:  2021-01-28       Impact factor: 3.615

8.  2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation.

Authors:  Shih-Yi Chuang; Chi-Yuan Chen; Shih-Chun Yang; Ahmed Alalaiwe; Chih-Hung Lin; Jia-You Fang
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 9.  Cannabinoids in the Pathophysiology of Skin Inflammation.

Authors:  Cristian Scheau; Ioana Anca Badarau; Livia-Gratiela Mihai; Andreea-Elena Scheau; Daniel Octavian Costache; Carolina Constantin; Daniela Calina; Constantin Caruntu; Raluca Simona Costache; Ana Caruntu
Journal:  Molecules       Date:  2020-02-04       Impact factor: 4.927

10.  Evaluation of the Influence of Adalimumab on the Expression Profile of Leptin-Related Genes and Proteins in Keratinocytes Treated with Lipopolysaccharide A.

Authors:  Beniamin Oskar Grabarek; Tomasz Kasela; Iwona Adwent; Barbara Zawidlak-Węgrzyńska; Ryszard Brus
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.